
BioVigil
Provides superior infection control and disease mitigation solutions that enhance patient care environments.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | N/A | N/A | - |
Total Funding | 000k |
Related Content
BioVigil provides an electronic hand hygiene compliance monitoring system designed to help hospitals achieve and sustain high levels of hand hygiene compliance. The system serves healthcare facilities by reminding and coaching staff on hand hygiene practices at every opportunity, thereby reducing healthcare-associated infections (HAIs) and improving patient satisfaction. Operating in the healthcare market, BioVigil's business model revolves around selling and maintaining these compliance systems, generating revenue through product sales and ongoing service contracts. The company targets hospitals and healthcare providers, offering a solution that not only enhances patient safety but also reduces costs associated with HAIs. With impressive outcomes such as an 18% reduction in staff absenteeism and a 45% reduction in central line-associated bloodstream infections (CLABSI) and catheter-associated urinary tract infections (CAUTI), BioVigil demonstrates significant value to its clients. The system has served 3 million patients annually and has shown substantial financial benefits, including an average reduction of $656,000 in unreimbursed care costs due to HAI improvements.
Keywords: hand hygiene, compliance monitoring, healthcare, HAIs, patient satisfaction, cost reduction, infection control, hospitals, staff coaching, electronic system.